About VIB (126)
Bio imaging core (1)
Business opportunities (18)
Cardiovascular medicine (27)
Cell biology (16)
Developmental biology (6)
Inflammation and immunity (64)
International PhD Program (1)
Model Organisms (2)
Plant biology (103)
Research Areas (5)
Science ethics (2)
Structural biology (26)
Systems biology (9)
BioInformatics Training and Service facility (1)
Research services (5)
Page Content Zone 1
Neurogenesis - Discovery of a new regulatory mechanism
28 January 2016
A mechanism, found by Bassem Hassan's team, is a simple reversible chemical modification, critical for the production of sufficient number of neurons, their differentiation and the development of the nervous system.
VIB researchers uncover new mechanism controlling plant root development
19 January 2016
“Discovering a new interaction partner of ACR4 is exciting because we now have more insight in the action mechanism of this important plant growth regulator.”
Complementary partners VIB and ILVO join forces
15 January 2016
On 15 January 2016, VIB and the Institute for Agriculture and Fisheries Research (ILVO) signed a strategic collaboration agreement.
Novel insights in the attachment of the bacterial carcinogen Helicobacter pylori
14 January 2016
This BabA protein proves to be a molecular chameleon that adapts it binding properties and preference for different ABO-blood group sugars according to their prevalence in different human populations.
Modifying the structure of wood alters plant microbiome
13 January 2016
Wout Boerjan: The results are especially important in allowing the interaction between trees and bacteria to be utilised to obtain higher and more sustainable production of, in this case, poplar wood for bioenergy.
VIB researchers discover possible strategy against stroke
7 January 2016
Research led by prof. Peter Carmeliet and dr. Annelies Quaegebeur (VIB/KU Leuven) indicates that inhibition of PHD1 offers protection against stroke, via an unexpected mechanism, raising hope for future stroke treatment.
Tech Lane Ghent Science Park
6 January 2016
The growth of the Biotech cluster in Ghent means that the available space at Technologiepark in Zwijnaarde is fully occupied. A number of other stakeholders have joined forces to start developing a new zone to the east of the Technologiepark.
Leuven Mindgate: dynamic network focusing on health, technology and creativity
6 January 2016
Leuven Mindgate brings partners together across sectors, government authorities and knowledge centers with the dual aim of guaranteeing sustainable development, innovation and prosperity in the Leuven region.
What a 'CERN' for agricultural science could look like
6 January 2016
Providing sufficient food to 9.2 billion people by 2050 in a changing climate will be a major challenge.
Hilde Windels (Biocartis) about the role of VIB in the Flemish biotech sector
5 January 2016
VIB wants to play a key role in the Flemish biotech sector. But how do others see us? We asked Hilde Windels, Biocartis’ Deputy CEO, who has been working in the Flemish biotech sector for almost 20 years.
VIB Discovery Sciences drives
4 January 2016
VIB’s mission is twofold: to conduct frontline research and to translate scientific breakthroughs into tangible benefits for society. VIB has endorsed the start of a strategic initiative called ‘VIB Discovery Sciences’.
First Closing of V-Bio Ventures
2 January 2016
V-Bio Ventures announced a first closing with capital commitments of € 63 million. We asked Christina Takke and Willem Broekaert, both Managing Partners and founders of V-Bio Ventures, to comment on what the next steps are.
Start me up! A closer look at new ventures based on breakthrough science
28 December 2015
VIB’s tech transfer system is a striking illustration of how ground-breaking science and impact on society go hand in hand. Our patents can lead to license agreements with existing companies, but also to brand-new ventures.
A novel mechanism that helps activated dendritic cells to initiate effective immunity
18 December 2015
Phagocytosis represents a critical innate barrier against infection and serves the clearance of extracellular microbes, infected and dying cells. The results are published in the December issue of the prestigious journal Immunity.
VIB Core Facilities: technology suites for better science
18 December 2015
In terms of new technologies VIB is experiencing more exciting times than ever. The same applies to VIB’s Core Facilities. As specialized units, they provide state-of-the-art equipment, expertise and experience.
Page Content Zone 2
Page Content Zone 3
Get news updates:
Follow us on Twitter
Like us on Facebook
Inflammation and immunity
Training and facilities
Int. Ph.D. Program